Diabetes mellitus: assessing fitness to drive
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
| ✘- Must not drive | ! - May continue to drive subject to medical advice and/or notifying DVLA | ✓- May continue to drive and need not notify DVLA |
Diabetes mellitus
Information sent to drivers
Insulin-treated drivers are sent a detailed letter from DVLA explaining the licensing requirements and driving responsibilities.responsibilities (see the INF294 leaflet in Appendix E).
All drivers with diabetes must follow the information provided in ‘Information for drivers with diabetes’, which includes a notice of when they must contact DVLA (see Appendix E).
Insulin-treated diabetes
Adequate awareness of hypoglycaemia
The Secretary of State’s Honorary Medical Advisory Panel on Driving and Diabetes has defined adequate awareness of hypoglycaemia as beingwhether able‘the licence holder/applicant [is] capable of bringing their vehicle to recognisea safe controlled stop’.
This is a matter of professional judgement and as a guide the duration of hypoglycaemic symptoms inexperienced timeshould be compatible with bringing a vehicle to safelya stopsafe thecontrolled vehicle.stop.
The reliance on alarms on glucose monitoring devices shouldare supplement, not replaceaccepted theas individual’sa ownsubstitute awarenessfor andadequate activesymptomatic self-monitoringor practices.physiological Theyawareness should be set at appropriate levels of abovehypoglycaemia 4.0mmol/Lexperienced whileby driving.the driver.
IfShould a driver becomesbecome dependentreliant on these alarms to recogniseadvise lowthem glucose,that they are hypoglycaemic they must stop driving and notify DVLA.
Impaired awareness of hypoglycaemia
ForThe Group 1 drivers, the Panel has also defined impaired awareness of hypoglycaemia asfor beingGroup unable1 todrivers recogniseas when‘an theinability glucoseto leveldetect isthe lowonset orof startinghypoglycaemia tobecause fall,of due to a total absence of warning symptoms.symptoms’.
Group 2 drivers must have full awareness of hypoglycaemia.
Severe hypoglycaemia
The law defines ‘severe’ as an episode of hypoglycaemia requiring the assistance of another person.
For Group 1 drivers,drivers hypoglycaemia- thatepisodes happensof hypoglycaemia occurring during established sleep isare no longer considered relevant for licensing purposes, unless there are concerns aboutregarding thetheir driver’shypoglycaemia ability to recognise low glucose.awareness.
Group 2 drivers - must report all episodes of severe hypoglycaemia requiring the helpassistance of another person, including sleep episodes.
ContinuousInterstitial glucose monitoring systems (CGM)
DriversThese shoulddevices useare amore devicewidely thatknown isas medicallyflash approvedglucose formonitoring non-adjunctivesystems use,(Flash meaningGM) itand isreal-time approvedcontinuous forglucose makingmonitoring treatmentsystems decisions based on CGM readings. This ensures the monitor meets the required safety and quality standards.(RT-CGM).
Group 1 and Group 2
These systems may be used for monitoring glucose at times relevant to driving in Group 1 and Group 2 vehicles. Users of these systems must carry finger prick capillary glucose testing equipment for driving purposes as there are times when a confirmatory finger prick blood glucose meterlevel asis required.
If using an interstitial fluid continuous glucose monitoring system (Flash GM or RT-CGM), the blood glucose level must be confirmed with a backup.finger Thisprick isblood essentialglucose reading in casethe following circumstances:
whenthe CGMglucosestopslevelworkingis4.0mmol/Lorbelowwhensymptomsofhypoglycaemiaarebeingexperiencedwhentheglucosemonitoringsystemgives readingsareadingthat doisnot matchconsistenthowwiththe personsymptomsfeelsbeingexperienced(for example, symptoms of hypoglycaemia butandnothelowsystemreading shown).For
doesmorenotdetails,indicatethis)-seetheINF294leafletinAppendix E.forfurtherdetails
Group 2
There is a legal requirement for Group 2 drivers to monitor their blood glucose for the purpose of Group 2 driving.
Flash GM and RT-CGM interstitial fluid glucose monitoring systems are not permitted for the purposes of Group 2 driving and licensing.
Group 2 drivers who use these devices must continue to monitor finger prick capillary blood glucose levels with the regularity defined below.
| Group 1 |
Group 2 Bus and lorry |
|---|---|
| ! - Must meet the criteria to drive and must notify DVLA. All the following criteria must be met for DVLA to license the person with insulin-treated diabetes for 1, 2 or 3 years: ■ adequate awareness of hypoglycaemia (being ■ has ■ practises appropriate glucose monitoring as defined below ■ not regarded as a likely risk to the public while driving ■ meets the visual standards for acuity and visual field (see the ■ no disqualifying complications of diabetes ■ under regular medical review |
! - Must meet the criteria to drive and must notify DVLA. All the following criteria must be met for DVLA to license the person with insulin-treated diabetes for 1 year (with annual review as indicated last below): ■ full awareness of hypoglycaemia ■ no episode of severe hypoglycaemia in the preceding 12 months ■ practises ■ must use a ■ demonstrates an understanding of the risks of hypoglycaemia ■ no disqualifying complications of diabetes that would mean a licence being refused or revoked, such as visual field defect (see the ■ under regular medical review |
Group 1 and Group 2 requirements for insulin-treated drivers licensed on review
The Secretary of State’s Honorary Medical Advisory Panel on Driving and Diabetes has defined the glucose self-monitoring requirements for licensing as follows.
Group 1 car and motorcycle
Glucose
glucosetesting mustnotakemoreplace:- at
than2hoursbeforethe start of the first journeyand - at least every 2 hours during
afterthedrivingjourneyhasstarted
A
- at
amaximum of 2 hours should pass between the pre-driving glucose test and the first glucose check performed after driving has started.Applicants
startedapplicantswill be asked to sign an undertaking to comply with the directions of the healthcare professionals treating their diabetes and to report any significant change in their condition to DVLA immediately.immediately
More frequent self-monitoring may be required with any greater risk of hypoglycaemia (such(physical asactivity, physical activity or altered meal routine).
Group 2 bus and lorry
Glucose testing must take place:
regularbloodglucosetesting–at least twice daily,dailyincluding on days when not drivingand- at
nomorethan2hoursbeforethe start of the first journeyand - at least every 2 hours during
afterthedrivingjourneyhasstarted
A
More frequent self-monitoring may be required with any greater risk of hypoglycaemia (such(physical asactivity, physicalaltered activitymeal orroutine), alteredin mealwhich routine).case Aa bus or lorry driver may be licensed if theythey:
useneedonetooruse more thanbloodone glucose metermeterswith a memory functionfunctionsto ensure 46weeks of readings whilewhilston insulin arethatwillbeavailable for assessment.assessment
How DVLA checks diabetes management requirements for insulin-treated Group 2 bus and lorry licensing
DVLA takes the following measures to ensure the requirements are met for the licensing of insulin-treated Group 2 bus and lorry drivers. Applicants must:drivers:
applicantsmuststop driving Group 2 vehicles when they commence insulin,insulinuntil DVLA has made a licensing decision- have
arrangesaanstableexaminationmedicaltoconditionbeforundertakenat least one month before starting a driving licence application - attend an examination every 12 months by an independent consultant specialist in diabetes
At
Applicantsmeter (not Continuous Glucose Monitoring System)
Recurrent severe hypoglycaemia guidance
Advice for Group 1 drivers who have had 2more orthan moreone episodesepisode of severe hypoglycaemia while awake in the last 12 months
✘- Must not drive and must notify DVLA.
DVLA will then carry out medical enquiries before a licensing decision is made.
Advice for Group 2 drivers after every episode of severe hypoglycaemia in the last 12 months
✘- Must not drive and must notify DVLA following all episodes of severe hypoglycaemia.
Severe hypoglycaemia whilst driving
All Group 1 and Group 2 drivers who experience an episode of severe hypoglycaemia whilst driving must not drive and must notify DVLA.
Impaired awareness of hypoglycaemia – ‘hypoglycaemia unawareness’
For Group 1 drivers, the Panel has also defined impaired awareness of hypoglycaemia as being unable to recognise when the glucose level is low or starting to fall, due to a total absence of warning symptoms.
Group 2 drivers must have full awareness of hypoglycaemia.
| Group 1 Car and motorcycle | Group 2 Bus and lorry |
|---|---|
| ✘- Must not drive and must notify DVLA. Driving may resume after a clinical report by a GP or consultant diabetes specialist confirms that adequate hypoglycaemia awareness has been regained. |
✘- Must not drive and must notify DVLA. The licence will be refused or revoked. Refer to the requirements for insulin-treated diabetes. |
Diabetes complications
Visual complications – affecting visual acuity or visual field
| Group 1 Car and motorcycle |
Group 2 Bus and lorry |
|---|---|
| ! - May need to stop driving and notify DVLA. See |
! See |
Renal complications
| Group 1 Car and motorcycle |
Group 2 Bus and lorry |
|---|---|
| ! - May need to stop driving and notify DVLA. See the |
! - May need to stop driving and notify DVLA. See |
Limb complications – including peripheral neuropathy
| Group 1 Car and motorcycle | Group 2 Bus and lorry | |
|---|---|---|
| Any complication such as peripheral neuropathy that means a driver must meet requirements (such as vehicle adaptations) for disabilities | ! - May need to stop driving and notify DVLA. See Appendix G, disabilities and vehicle adaptations. Limb problems or amputations are of themselves unlikely to prevent driving since they may be assisted by suitable vehicle adaptations. The ability to safely control a vehicle at all times is the essential requirement. |
! - May need to stop driving and notify DVLA. See Appendix G, disabilities and vehicle adaptations. Limb problems or amputations are of themselves unlikely to prevent driving since they may be assisted by suitable vehicle adaptations. The ability to safely control a vehicle at all times is the essential requirement. |
Temporary insulin treatment – including gestational diabetes or post-myocardial infarction
| Group 1 Car and motorcycle |
Group 2 Bus and lorry |
|
|---|---|---|
| Trial participants for oral or inhaled insulin are also examples to be included as receiving temporary insulin treatment | ! - May drive and need not notify DVLA, provided: ■ under medical supervision ■ not advised by clinician as at risk of disabling hypoglycaemia ! - May continue to drive but must notify DVLA if: ■ disabling hypoglycaemia occurs ■ treatment continues for more than 3 months – or in gestational diabetes, continues for 3 months after delivery |
✘- Must notify DVLA and meet the above standards. |
Diabetes treated by medication other than insulin
Severe hypoglycaemia
The law defines ‘severe’ as an episode of hypoglycaemia requiring the assistance of another person.
All Group 1 and Group 2 drivers who experience an episode of severe hypoglycaemia whilst driving must not drive and must notify DVLA.
Managed by tablets carrying hypoglycaemia risk
| Group 1 Car and motorcycle |
Group 2 Bus and lorry |
|
|---|---|---|
| Including sulphonylureas and glinides (for example Repaglinide, Nateglinide) | ! - May drive and need not notify DVLA, provided ■ has ■ has not experienced 2 or more episodes of severe hypoglycaemia while awake in the last 12 months and the most recent episode occurred more than 3 months ago ■ is It is advisable |
! - May drive but must notify DVLA. All the following criteria must be met for DVLA to issue a licence for 1, 2 or 3 years: ■ no episode of severe hypoglycaemia in the last 12 months ■ full awareness of hypoglycaemia ■ regular self-monitoring of ■ demonstrates an understanding of the risks of hypoglycaemia ■ under regular medical review ■ has no disqualifying complications of diabetes |
Managed by other medication - such medication includes Metformin, DPP-4 inhibitors (gliptins), SGLT2 inhibitors, GLP-1 agonists and non-insulin injectables
| Group 1 Car and motorcycle |
Group 2 Bus and lorry |
|
|---|---|---|
| ! - May drive and need not notify DVLA, provided the requirements set out in Appendix E are met and the driver is under regular medical review. Must |
! - May drive but must notify DVLA. DVLA may issue a licence if the requirements set out in Appendix E are met and the driver is under regular medical review. Must have |
Diabetes managed by dietdiet/lifestyle or lifestyle alone
| Group 1 Car and motorcycle |
Group 2 Bus and lorry |
|---|---|
| ✓- May drive and need not notify DVLA, Must |
✓- May drive and need not notify DVLA, Must |
Severe hypoglycaemia due to causes other than diabetes management
Examples include hypoglycaemia post-bariatric surgery or in association with eating disorders, and the restriction applies for both car and motorcycle, and bus and lorry drivers.
Severe hypoglycaemia
The law defines ‘severe’ as an episode of hypoglycaemia requiring the assistance of another person.
✘- If there are episodes of severe hypoglycaemia from any cause other than diabetes treatment driving must stop and the driver must notify DVLA.DVLA
| Group 1 Car and motorcycle |
Group 2 Bus and lorry |
|---|---|
| The following criteria must be met for DVLA to license ■ adequate awareness of hypoglycaemia (being able to recognise symptoms in time to safely stop the vehicle) ■ practices appropriate glucose monitoring as defined in the section ■ demonstrates an understanding of the risks of hypoglycaemia ■ not regarded as a likely risk to the public when driving ■ remains under regular clinical review for the management of the underlying medical condition |
The following criteria must be met for DVLA to license ■ full awareness of hypoglycaemia ■ no episode of severe hypoglycaemia in the preceding 12 months ■ practices appropriate glucose monitoring as ■ demonstrates an understanding of the risks of hypoglycaemia ■ not regarded as a likely risk to the public when driving ■ remains under regular clinical review for the management of the underlying medical condition |
Group 1 car and motorcycle
Glucose
glucosetesting mustnotakemoreplace:- at
than2hoursbeforethe start of the first journeyand - at
everyleast2everyhoursafterdrivinghasstarted amaximumof2 hours duringshouldpassbetweenthe journeypre-drivingglucosetestandthefirstglucosecheckperformedafterdrivinghasstarted
More frequent self-monitoring may be required with any greater risk of hypoglycaemia (such
(physicalasactivity,physical activity or altered meal routine).Group 2 bus and lorry
Glucose testing must take place:
regularbloodglucosetesting–at least twice daily,dailyincluding on days when not drivingand- at
nomorethan2hoursbeforethe start of the first journeyand - at least every 2 hours during
afterthedrivingjourneyhasstarted
A
- at
amaximum of 2 hours should pass between the pre-driving glucose test and the first glucose check performed after driving has started.started
More frequent self-monitoring may be required with any greater risk of hypoglycaemia (such(physical asactivity, physical activity or altered meal routine).
Pancreas transplant
| Group 1 Car and motorcycle | Group 2 Bus and lorry |
|---|---|
| ! - May drive but must notify DVLA. Licensing is on the provision that the patient has no disqualifying condition. If the patient is on insulin, refer to insulin-treated diabetes. |
! - May drive but must notify DVLA. Licensing is on the provision that the patient has no disqualifying condition. If the patient is on insulin, refer to insulin-treated diabetes. |
Islet cell transplantation
| Group 1 Car and motorcycle | Group 2 Bus and lorry |
|---|---|
| ! - May drive but must notify DVLA. Licensing is on the provision that the patient has no disqualifying condition. If the patient is on insulin, refer to insulin-treated diabetes. |
! - May drive but must notify DVLA. Licensing is on the provision that the patient has no disqualifying condition. If the patient is on insulin, refer to insulin-treated diabetes. |
Seizures provoked by hypoglycaemia
Seizures provoked by hypoglycaemia now require a period off driving due to the prospective risk of a further seizure.
| Group 1 Car and motorcycle | Group 2 Bus and lorry |
|---|---|
| ✘ - Must not drive and must notify DVLA. See ‘Provoked seizures’ under Epilepsy and seizures. |
✘ - Must stop driving and must notify DVLA. See ‘Provoked seizures’ under Epilepsy and seizures. |
Updates to this page
-
Numerous changes to the wording of this chapter to incorporate the law change which allows Group 2 drivers to use Continuous Glucose Monitoring Systems (CGMS) whilst driving.
-
Amendment to the duration of blood glucose readings taken whilst on insulin under the section ‘How DVLA checks diabetes management requirements for insulin-treated Group 2 bus and lorry licensing’. Updating references to the appendices.
-
Changes to the section 'managed by tablets carrying hypoglycaemia risk' to reflect more accurately the exact requirements for glucose monitoring for Group 1. Changes to the section on 'pancreas transplant' to update requirements for licensing for Group 2. Changes to the section on 'islet cell transplantation' to update requirements for licensing for Group 1 and Group 2. Changes to the time period for glucose monitoring for Group 2 from 3 months to 6 weeks, in order to mirror changes to the D4 in February 2023.
-
Clarification of medical standard for diabetes managed by medication other than insulin Clarification of medical standard for severe hypoglycaemia due to causes other than diabetes management
-
Clarification regarding blood glucose reading requirements for Group 2 licensing when insulin treatment is first notified Clarification of medical standards for hypoglycaemia due to causes other than insulin treatment
-
Confirmation of the need for physiological hypoglycaemic awareness when using Continuous Glucose Monitoring (CGM) devices. Clarification of the required frequency of examination with the applicant’s usual doctor in the case of Group 2 drivers receiving insulin treatment.
-
Introduction of guidance for the use of continuous glucose monitoring systems for Group 1 driving. Advice regarding severe hypoglycaemia occurring whilst driving.
-
Clarification of asleep/awake severe hypoglycaemia and relevant timescales of episodes. Clarification of use of CGMS.
-
As a consequence of changes in European legislation amendments have been required to the applicable standards for: diabetes mellitus managed by insulin; and diabetes mellitus managed by medication which has a risk of causing hypoglycaemia (low blood sugar).
-
Content updated
-
First published.
Update history
2025-11-07 00:01
Numerous changes to the wording of this chapter to incorporate the law change which allows Group 2 drivers to use Continuous Glucose Monitoring Systems (CGMS) whilst driving.
2025-09-26 13:39
Amendment to the duration of blood glucose readings taken whilst on insulin under the section ‘How DVLA checks diabetes management requirements for insulin-treated Group 2 bus and lorry licensing’.Updating references to the appendices.
2024-01-15 11:30
Changes to the section ‘managed by tablets carrying hypoglycaemia risk’ to reflect more accurately the exact requirements for glucose monitoring for Group 1.Changes to the section on ‘pancreas transplant’ to update requirements for licensing for Group 2.Changes to the section on ‘islet cell transplantation’ to update requirements for licensing for Group 1 and Group 2.Changes to the time period for glucose monitoring for Group 2 from 3 months to 6 weeks, in order to mirror changes to the D4 in February 2023.
2022-06-22 10:20
Clarification of medical standard for diabetes managed by medication other than insulinClarification of medical standard for severe hypoglycaemia due to causes other than diabetes management